Export this Abstract | Print this Abstract | Add to my preferred Abstracts list | My preferred Abstracts list (0) | Back to Search
Development and validation method for quantitative determination of rifampicin in human plasma and its application in bioequivalence test
- At: 2017 FIP Congress in Seoul (South Korea)
- Type: Poster
- By: LUKITANINGSIH, Endang (Gadjah Mada University, Pharmaceutical Chemistry Department, Yogyakarta, Indonesia)
- Co-author(s): Endang Lukitaningsih:
Fathul Jannah: Advanced Pharmaceutical Sciences lab, Gadjah Mada University, Yogyakarta, Indonesia
Arief Rahman Hakim: Pharmacology and Clinical Pharmacy, Gadjah Mada University, Yogyakarta, Indonesia
Ratna Dewi Puspita: Gadjah Mada University Hospital, Gadjah Mada University, Yogyakarta, Indonesia
Zullies Ikawati: Pharmacology and Clinical Pharmacy, Gadjah Mada University, Yogyakarta, Indonesia
BackgroundRifampicin has been used worldwide as first line drug-prescribed throughout tuberculosis therapy
PurposeThis study aims to develop and to validate an HPLC method couple with a UV detection for determination of rifampicin for bioequivalence study.
MethodsThe chromatographic separation was achieved on a RP-C18 column (LachromHitachi, 250 x.. The access to the whole abstract and the presentation file is available to FIP members and to congress participants of that specific congress.
Last update 4 October 2019